RxDoctor Payments Data

Alvin Williams

Family · Bogalusa, LANPI 1083138226

Payments from drug & device makers

$698in general payments, 2019–2025

Across 37 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$137
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$119
  • Lilly USA, LLC$75
  • Bayer$58
  • AbbVie$55
  • Dexcom, Inc.$38
  • plus $214 from 10 others

What the payments were for

  • Food & beverage$698100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$698 in reported general payments places this provider in the 55th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$11,381
Medicare patients
85
Services billed
377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide26$26,492
FarxigaDapagliflozin Propanediol24$13,747
LinzessLinaclotide12$6,270
SymbicortBudesonide/Formoterol Fumarate15$3,997
Levocetirizine Dihydrochloride68$461
Albuterol Sulfate HfaAlbuterol Sulfate18$452
Gabapentin61$423
Amlodipine Besylate105$422
Duloxetine Hcl35$289
Atorvastatin Calcium58$281
Losartan Potassium43$258
Pantoprazole Sodium63$219
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide14$186
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$186
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$180

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$75$26,49226 claims
AbbVieLinzess$55$6,27012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,610 family providers in Louisiana.

Other family in Bogalusa

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →